tiprankstipranks
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ:SXTP
US Market
SXTP
60 Degrees Pharmaceuticals, Inc.
RESEARCH TOOLSreports
Want to see SXTP full AI Analyst Report?

60 Degrees Pharmaceuticals, Inc. (SXTP) Ratios

240 Followers

60 Degrees Pharmaceuticals, Inc. Ratios

SXTP's free cash flow for Q4 2025 was $0.60. For the 2025 fiscal year, SXTP's free cash flow was decreased by $ and operating cash flow was $-4.74. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.66 2.66 3.25 2.55 0.05
Quick Ratio
 2.30 2.30 2.98 2.39 0.02
Cash Ratio
 0.82 0.82 1.00 0.76 0.01
Solvency Ratio
 -3.67 -3.67 -4.37 -1.23 -0.24
Operating Cash Flow Ratio
 -5.32 -3.72 -3.41 -1.60 -0.04
Short-Term Operating Cash Flow Coverage
 -1.12K -780.78 -643.88 -517.89 -0.05
Net Current Asset Value
$ 2.91M$ 2.91M$ 3.58M$ 4.26M$ -24.35M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.02 17.28
Debt-to-Equity Ratio
 0.04 0.04 0.04 0.04 -0.95
Debt-to-Capital Ratio
 0.04 0.04 0.04 0.03 -19.35
Long-Term Debt-to-Capital Ratio
 0.04 0.04 0.04 0.03 -0.06
Financial Leverage Ratio
 1.55 1.55 1.43 1.60 -0.06
Debt Service Coverage Ratio
 -439.02 -439.02 -472.55 -0.62 -0.08
Interest Coverage Ratio
 -994.05 -994.05 -1.23K -2.25 -0.44
Debt to Market Cap
 0.12 0.11 0.05 <0.01 0.01
Interest Debt Per Share
 0.24 0.24 1.44 2.48 18.27
Net Debt to EBITDA
 0.19 0.19 0.19 1.38 -10.50
Profitability Margins
Gross Profit Margin
22.26%22.26%36.67%-87.15%-93.71%
EBIT Margin
-732.05%-732.05%-1308.07%-602.16%-980.22%
EBITDA Margin
-723.80%-723.80%-1297.58%-562.58%-944.92%
Operating Profit Margin
-771.64%-771.64%-1598.97%-2032.78%-784.22%
Pretax Profit Margin
-732.82%-732.82%-1309.37%-1503.93%-2767.50%
Net Profit Margin
-732.82%-732.82%-1308.01%-1485.06%-2769.49%
Continuous Operations Profit Margin
-732.82%-732.82%-1309.41%-1504.02%-2767.73%
Net Income Per EBT
100.00%100.00%99.90%98.75%100.07%
EBT Per EBIT
94.97%94.97%81.89%73.98%352.90%
Return on Assets (ROA)
-137.31%-137.31%-137.99%-48.38%-476.54%
Return on Equity (ROE)
-204.22%-212.76%-196.93%-77.32%26.22%
Return on Capital Employed (ROCE)
-220.20%-220.20%-236.83%-104.17%7.74%
Return on Invested Capital (ROIC)
-219.65%-219.65%-236.32%-103.70%118.61%
Return on Tangible Assets
-143.30%-143.30%-141.86%-49.83%-545.63%
Earnings Yield
-687.13%-541.58%-271.04%-1.55%-0.38%
Efficiency Ratios
Receivables Turnover
 1.97 1.97 1.25 1.10 4.86
Payables Turnover
 0.54 0.54 0.38 0.94 0.57
Inventory Turnover
 1.19 1.19 0.87 1.02 0.83
Fixed Asset Turnover
 4.08 4.08 4.06 3.56 6.58
Asset Turnover
 0.19 0.19 0.11 0.03 0.17
Working Capital Turnover Ratio
 0.28 0.30 0.15 -0.03 -0.02
Cash Conversion Cycle
 -189.64 -189.64 -243.42 302.19 -127.52
Days of Sales Outstanding
 185.01 185.01 292.41 332.99 75.16
Days of Inventory Outstanding
 306.74 306.74 420.02 358.55 437.78
Days of Payables Outstanding
 681.39 681.39 955.86 389.35 640.46
Operating Cycle
 491.75 491.75 712.43 691.54 512.94
Cash Flow Ratios
Operating Cash Flow Per Share
 -14.62 -10.22 -49.70 -4.59 -0.70
Free Cash Flow Per Share
 -14.81 -10.54 -51.29 -4.71 -0.74
CapEx Per Share
 0.19 0.33 1.59 0.12 0.04
Free Cash Flow to Operating Cash Flow
 1.01 1.03 1.03 1.03 1.06
Dividend Paid and CapEx Coverage Ratio
 -78.13 -31.41 -31.19 -39.20 -16.80
Capital Expenditure Coverage Ratio
 -78.13 -31.41 -31.19 -39.20 -16.80
Operating Cash Flow Coverage Ratio
 -64.16 -44.83 -36.23 -26.31 -0.05
Operating Cash Flow to Sales Ratio
 -9.75 -6.81 -9.30 -17.92 -4.52
Free Cash Flow Yield
-769.24%-519.44%-198.81%-1.92%-0.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.15 -0.18 -0.37 -64.36 -262.63
Price-to-Sales (P/S) Ratio
 1.31 1.35 4.83 955.82 7.27K
Price-to-Book (P/B) Ratio
 0.32 0.39 0.73 49.77 -68.86
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.13 -0.19 -0.50 -52.02 -1.52K
Price-to-Operating Cash Flow Ratio
 -0.11 -0.20 -0.52 -53.35 -1.61K
Price-to-Earnings Growth (PEG) Ratio
 -0.01 <0.01 >-0.01 5.74 -5.89
Price-to-Fair Value
 0.32 0.39 0.73 49.77 -68.86
Enterprise Value Multiple
 <0.01 >-0.01 -0.18 -168.52 -780.26
Enterprise Value
 -66.81K 3.24K 1.43M 240.40M 1.65B
EV to EBITDA
 <0.01 >-0.01 -0.18 -168.52 -780.26
EV to Sales
 -0.07 <0.01 2.35 948.05 7.37K
EV to Free Cash Flow
 <0.01 >-0.01 -0.25 -51.60 -1.54K
EV to Operating Cash Flow
 <0.01 >-0.01 -0.25 -52.92 -1.63K
Tangible Book Value Per Share
 4.71 4.71 33.42 4.62 -16.82
Shareholders’ Equity Per Share
 5.17 5.17 35.51 4.92 -16.31
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 >-0.01 >-0.01 >-0.01
Revenue Per Share
 1.50 1.50 5.35 0.26 0.15
Net Income Per Share
 -10.99 -10.99 -69.93 -3.80 -4.28
Tax Burden
 1.00 1.00 1.00 0.99 1.00
Interest Burden
 1.00 1.00 1.00 2.50 2.82
Research & Development to Revenue
 2.09 2.09 8.21 2.73 2.35
SG&A to Revenue
 6.25 6.25 8.27 16.73 5.84
Stock-Based Compensation to Revenue
 0.37 0.00 5.94 0.00 0.00
Income Quality
 1.26 0.00 0.71 1.21 0.16
Currency in USD